Riboflavin Biosynthetic and Regulatory Factors as Potential Novel Anti‐Infective Drug Targets
Authors:
- Quanxin LongQLQuanxin Long
- Lei JiLJLei Ji
- Honghai WangHWHonghai Wang
- Jianping XieJXJianping Xie
- 22 February 2010
- journal article
- review article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 75 (4) , 339-347
Abstract
Riboflavin (vitamin B2) is the direct precursor of redox enzyme cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are essential for multiple cell physiology. The riboflavin biosynthetic pathway is regarded as a rich resource for therapeutic targets for broad spectrum antibiotics. Enzymatic pathways, regulatory factors of the riboflavin biosynthesis, and relevant drug discovery are summarized in this review. The novel riboswitch regulatory mechanism of riboflavin metabolism is also described. A compendium of chemical modulators of riboflavin biosynthesis and regulatory networks is listed and such demonstrates the promise of riboflavin biosynthesis and regulatory mechanisms as potential therapeutic targets for novel antibiotic drug discovery.Keywords
This publication has 52 references indexed in Scilit:
- Characterization of Riboflavin (Vitamin B2) Transport Proteins fromBacillus subtilisandCorynebacterium glutamicumJournal of Bacteriology, 2007
- Structure of the S-adenosylmethionine riboswitch regulatory mRNA elementNature, 2006
- The Riboflavin Transporter RibU in Lactococcus lactis : Molecular Characterization of Gene Expression and the Transport MechanismJournal of Bacteriology, 2006
- Crystallographic Studies on Decameric Brucella spp. Lumazine Synthase: A Novel Quaternary Arrangement Evolved for a New Function?Journal of Molecular Biology, 2005
- Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysisComputational Biology and Chemistry, 2005
- Evolution of Vitamin B2 Biosynthesis. A Novel Class of Riboflavin Synthase in ArchaeaJournal of Molecular Biology, 2004
- Massive gene decay in the leprosy bacillusNature, 2001
- The atomic structure of pentameric lumazine synthase from Saccharomyces cerevisiae at 1.85 Å resolution reveals the binding mode of a phosphonate intermediate analogue 1 1Edited by R. HuberJournal of Molecular Biology, 2000
- Design and synthesis of 6-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-hexylphosphonic acid, a potent inhibitor of lumazine synthaseBioorganic & Medicinal Chemistry Letters, 1999
- Molecular cloning and characterisation of the ribC gene from Bacillus subtilis : a point mutation in ribC results in riboflavin overproductionMolecular Genetics and Genomics, 1997